Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

Recruiting Observational Study
Spinal Cord Injuries Pain, Neuropathic Nociceptive Pain Neuropathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
University of Zurich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenoty…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Spinal injury cohort - general inclusion criteria: * Aged between 18-80 years * Traumatic and non-traumatic etiology * Para- and tetraplegic SCI * Complete and incomplete SCI * SCI with and without neuropathic pain * Additional inclusion criteria for longitudinal study: * SCI …
Contacts

Michèle Hubli, PD Dr.

+41 44 510 72 03

michele.hubli@balgrist.ch

CONTACT